(RTTNews) - InMode Ltd. (INMD), a medtech company, Wednesday announced the appointment of Moshik Itzkovich as Chief Financial Officer and Shlomo Nass as Chairman of the company, effective immediately. Itzkovich takes over from Yair Malca, who stepped down earlier this month. Most recently, Moshik was the Senior Vice President of Finance of InMode and has held senior finance roles at the company pr...
(RTTNews) - InMode Ltd. (INMD), a medtech company, Wednesday announced the appointment of Moshik Itzkovich as Chief Financial Officer and Shlomo Nass as Chairman of the company, effective immediately. Itzkovich takes over from Yair Malca, who stepped down earlier this month. Most recently, Moshik was the Senior Vice President of Finance of InMode and has held senior finance roles at the company previously. Nass succeeds Michael Anghel, who retired earlier this month, in leading the board as its chairman. In pre-market activity, INMD shares were trading at $13.98, up 0.07% on the Nasdaq. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Investors will get highly anticipated quarterly results from Nvidia (NVDA) on Wednesday in what’s expected to be the marquee earnings event of the week. Nvidia’s report serves as a barometer of artificial intelligence trade and comes as the AI chipmaker faces increasing competition from rivals such as Cerebras (CBRS) and AMD (AMD), as well as its customers Amazon (AMZN) and Google (GOOG). So far t...
Investors will get highly anticipated quarterly results from Nvidia (NVDA) on Wednesday in what’s expected to be the marquee earnings event of the week. Nvidia’s report serves as a barometer of artificial intelligence trade and comes as the AI chipmaker faces increasing competition from rivals such as Cerebras (CBRS) and AMD (AMD), as well as its customers Amazon (AMZN) and Google (GOOG). So far this earnings season, S&P 500 companies have impressed market watchers by printing profits, even amid ongoing risks from the Iran war, and the index is on track for double-digit earnings growth. Reports from semiconductor companies so far underscore that the artificial intelligence boom remains a key market driver. Also reporting this week are a handful of retail companies, including The Home Depot (HD), TJX Companies (TJX), Lowe’s Companies (LOW), Target Corporation (TGT), and Walmart (WMT), which will provide insights on the state of the US consumer. LIVE 5 updates
Arcos Dorados Holdings Inc. press release ( ARCO ): Q1 GAAP EPS of $0.17. Revenue of $1.21B (+12.0% Y/Y) in-line. Systemwide comparable sales rose 16.0% in the first quarter of 2026, supporting strong market share performance across the business. Consolidated Adjusted EBITDA1 in the first quarter was $118.0 million, up 29.3% versus the prior year period and the Company’s highest result for a first...
Arcos Dorados Holdings Inc. press release ( ARCO ): Q1 GAAP EPS of $0.17. Revenue of $1.21B (+12.0% Y/Y) in-line. Systemwide comparable sales rose 16.0% in the first quarter of 2026, supporting strong market share performance across the business. Consolidated Adjusted EBITDA1 in the first quarter was $118.0 million, up 29.3% versus the prior year period and the Company’s highest result for a first quarter. Consolidated Adjusted EBITDA margin expanded 120 basis points year-over-year to 9.7%. More on Arcos Dorados Holdings Inc. Arcos Dorados Holdings Inc. 2025 Q4 - Results - Earnings Call Presentation Arcos Dorados: Q4 Earnings Don't Merit An Upgrade Arcos Dorados Holdings Inc. (ARCO) Q4 2025 Earnings Call Transcript Arcos Dorados Holdings Inc. Q1 Earnings Preview Arcos Dorados Holdings Inc. Q4 2025 Earnings Preview
Jeenah Moon/Getty Images News Pfizer ( PFE ) on Wednesday announced that it has begun a Phase 3 trial for its 25-valent pneumococcal vaccine, PF-07872412 (25vPnC), for infants after the shot outperformed its pneumococcal 20-valent conjugate vaccine, Prevnar 20, in a mid-stage trial. 25vPnC is the New York-based pharma giant’s fourth-generation pneumococcal conjugate vaccine targeting Streptococcus...
Jeenah Moon/Getty Images News Pfizer ( PFE ) on Wednesday announced that it has begun a Phase 3 trial for its 25-valent pneumococcal vaccine, PF-07872412 (25vPnC), for infants after the shot outperformed its pneumococcal 20-valent conjugate vaccine, Prevnar 20, in a mid-stage trial. 25vPnC is the New York-based pharma giant’s fourth-generation pneumococcal conjugate vaccine targeting Streptococcus pneumoniae, the bacteria responsible for pneumonia. It is designed to cover 25 serotypes of Streptococcus pneumoniae, including 20 serotypes already covered by Prevnar 20 and serotype 3, a primary cause of invasive pneumococcal disease and complicated pneumonia in children. Citing a Phase 2 trial in healthy infants, the company noted that compared to the FDA-approved Prevnar 20, 25vPnC was associated with an immune response that was nearly 15-fold higher against serotype 3 as measured by geometric mean titers one month after dose 4. “Pfizer is confident that the required non-inferiority thresholds may be achieved for the pediatric Phase 3 program,” the company said, referring to a pivotal late-stage program started in May 2026 evaluating 25vPnC against Prevnar 20. Regarding tolerability, the company added that the investigational vaccine was well-tolerated with no new safety concerns. Additionally, Pfizer ( PFE ) announced plans for a fifth-generation pneumococcal vaccine candidate designed to cover 35 serotypes, noting that its adult vaccine is expected to enter clinical development by the end of this year, subject to regulatory feedback. More on Pfizer Why Pfizer Stock Still Looks Deeply Undervalued In 2026 Pfizer's Turnaround Is Taking Shape Pfizer: Don't Pass On This Dirt-Cheap Buying Opportunity HHS rescinds vaccine panel charter citing 'administrative error' FDA leadership fallout continues as acting CDER Director Hoeg departs
Palantir (PLTR +0.11%) has been one of the most popular artificial intelligence (AI) stock picks over the past few years. However, its stock has faltered as of late. The stock has failed to meaningfully participate in the AI rally that kicked off in April, and is down around 35% from its all-time highs. Furthermore, the company reported a blowout first quarter, yet the stock hasn't budged. This ma...
Palantir (PLTR +0.11%) has been one of the most popular artificial intelligence (AI) stock picks over the past few years. However, its stock has faltered as of late. The stock has failed to meaningfully participate in the AI rally that kicked off in April, and is down around 35% from its all-time highs. Furthermore, the company reported a blowout first quarter, yet the stock hasn't budged. This may look like a genius buying opportunity for Palantir stock if you missed out on the initial rise. But is it a solid buy now or a trap? Palantir's attractiveness depends on what you value as an investor Depending on how you look at Palantir's stock, it's either a no-brainer buy or a company to stay far away from. This dichotomy makes the stock hard to analyze, as it really comes down to individual investor preference. From a growth standpoint, Palantir is crushing it. Its data analytics AI platform has been supercharged with the integration of generative AI. This has caused monster growth and allows Palantir's platform to perform tasks that humans normally would have had to do. With AI, insights are available nearly instantly, allowing anyone with decision-making authority to have the best information available at all times. The platform was originally catered to government use, but it has now stretched into the commercial space. Expand NASDAQ : PLTR Palantir Technologies Today's Change ( 0.11 %) $ 0.15 Current Price $ 135.29 Key Data Points Market Cap $324B Day's Range $ 133.62 - $ 137.46 52wk Range $ 118.93 - $ 207.52 Volume 1.9K Avg Vol 48M Gross Margin 84.07 % Both commercial and government divisions are thriving, with commercial revenue rising 95% year over year to $774 million in Q1, and government revenue increasing 76% to $858 million. This led to an overall growth rate of 85% year over year. Palantir isn't just a growth-at-all-costs business either; it put up an impressive 53% net income margin in Q1. That's incredible growth and profitability combined into one, and...
Wall Street futures pointed moderately higher pre-bell Wednesday as traders took positions ahead of Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles.
Wall Street futures pointed moderately higher pre-bell Wednesday as traders took positions ahead of Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles.
(RTTNews) - While reporting financial results for the second quarter on Wednesday, semiconductor company Analog Devices, Inc. (ADI) provided earnings and revenue guidance for the third quarter of fiscal 2026. For the third quarter, the company projects earnings in a range of $2.45 to $2.75 per share and adjusted earnings in a range of $3.15 to $3.45 per share on projected revenues between $3.8 bil...
(RTTNews) - While reporting financial results for the second quarter on Wednesday, semiconductor company Analog Devices, Inc. (ADI) provided earnings and revenue guidance for the third quarter of fiscal 2026. For the third quarter, the company projects earnings in a range of $2.45 to $2.75 per share and adjusted earnings in a range of $3.15 to $3.45 per share on projected revenues between $3.8 billion and $4.00 billion. The company's Board of Directors declared a quarterly cash dividend of $1.10 per outstanding share of common stock, payable on June 16, 2026 to all shareholders of record at the close of business on June 2, 2026. In Wednesday's pre-market trading, ADI is trading on the Nasdaq at $405.00, down $9.31 or 2.25 percent. For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Arteris, Inc. has announced that its semiconductor technology has been adopted by Li Auto for their intelligent vehicles, specifically incorporating the technology into the company's autonomous driving systems-on-chip (SoCs) in the new L9 Livis high-tech SUV. This deployment marks a significant step in the integration of AI capabilities within the automotive sector, supporting Li Auto's high-perfo...
Arteris, Inc. has announced that its semiconductor technology has been adopted by Li Auto for their intelligent vehicles, specifically incorporating the technology into the company's autonomous driving systems-on-chip (SoCs) in the new L9 Livis high-tech SUV. This deployment marks a significant step in the integration of AI capabilities within the automotive sector, supporting Li Auto's high-performance computing needs while meeting energy efficiency and safety requirements. Arteris FlexNoC network-on-chip (NoC) IP and Magillem software play a crucial role in optimizing data movement and integrating various processing elements to balance performance and power efficiency in Li Auto's vehicles. This collaboration highlights the growing importance of semiconductor solutions in the advancement of smart vehicle technology. In other market news, was a notable mover up 17.4% and ending trading at CN¥258.94. In the meantime, softened, down 8.3% to end trading at NT$2,260.00. Advertisement Best AI Chip Stocks finished trading at $698.74 up 2.5%. finished trading at $698.74 up 2.5%. closed at $220.61 down 0.8%. On Monday, NVIDIA partnered with Blue Yonder to advance autonomous supply chain AI and with Dell to offer a scalable, secure desk-side AI solution. closed at $220.61 down 0.8%. On Monday, NVIDIA partnered with Blue Yonder to advance autonomous supply chain AI and with Dell to offer a scalable, secure desk-side AI solution. closed at $414.05 down 1.6%. Turning Ideas Into Actions Discover the full array of 124 , featuring , and , right here. Ready To Venture Into Other Investment Styles? This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focu...
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Oracle (NYSE:ORCL) is set to become the first cloud provider to deploy Nvidia's next generation Vera CPUs at hyperscale. Oracle Cloud Infrastructure plans to roll out hundreds of thousands of Nvidia Vera CPUs, with deployment sc...
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Oracle (NYSE:ORCL) is set to become the first cloud provider to deploy Nvidia's next generation Vera CPUs at hyperscale. Oracle Cloud Infrastructure plans to roll out hundreds of thousands of Nvidia Vera CPUs, with deployment scheduled to start in 2026. The rollout is aimed at supporting large scale AI workloads and expanding Oracle's AI focused cloud services for enterprise customers. For investors watching how large cloud providers are positioning around AI, this move places Oracle firmly in the race to supply infrastructure for data intensive workloads. Nvidia Vera CPUs are viewed as a meaningful step in AI computing hardware, and Oracle is linking its cloud strategy to this new platform as enterprises look for more powerful and efficient AI infrastructure. Looking ahead, the scale of the planned deployment signals Oracle's priorities for data center build out and AI related services. The follow through on this plan, including the pace at which Oracle can bring these resources online and attract AI focused workloads, will be important areas to monitor as 2026 approaches. Stay updated on the most important news stories for Oracle by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Oracle. NYSE:ORCL Earnings & Revenue Growth as at May 2026 📰 Beyond the headline: 2 risks and 3 things going right for Oracle that every investor should see. Oracle’s plan to deploy Nvidia’s Vera CPUs at hyperscale ties directly into its push to be a core AI infrastructure partner for large enterprises and AI-focused customers. Being the first cloud provider to roll out Vera at this scale can help Oracle position Oracle Cloud Infrastructure as a place where customers run both training and inference for large, data intensive models, in competition with Amazon...
记者从擎天租方面了解到，已于近期完成A轮及A+轮融资，融资金额达数亿元。本轮融资完成后，擎天租估值达到70亿元，正式跻身独角兽企业行列。据了解，本轮融资将重点用于RaaS（Robot as a Service，机器人即服务）体系建设和工业等场景拓展，推动机器人从“活动现场用起来”，进入工业制造、园区运营、仓储物流、商业服务等更接近生产与运营一线的真实场景。(科创板日报)
记者从擎天租方面了解到，已于近期完成A轮及A+轮融资，融资金额达数亿元。本轮融资完成后，擎天租估值达到70亿元，正式跻身独角兽企业行列。据了解，本轮融资将重点用于RaaS（Robot as a Service，机器人即服务）体系建设和工业等场景拓展，推动机器人从“活动现场用起来”，进入工业制造、园区运营、仓储物流、商业服务等更接近生产与运营一线的真实场景。(科创板日报)
Seeking Alpha More on ZIM Integrated ZIM Integrated: The Sakal $4.5B Bid Just Made A Done Deal Better ZIM Integrated: Rating Downgrade Due To Dividend Uncertainties ZIM Integrated Shipping: I'm Not Playing The Merger Roulette ZIM Integrated GAAP EPS of -$0.71 misses by $0.33, revenue of $1.4B misses by $60M ZIM Integrated Q1 2026 Earnings Preview
Seeking Alpha More on ZIM Integrated ZIM Integrated: The Sakal $4.5B Bid Just Made A Done Deal Better ZIM Integrated: Rating Downgrade Due To Dividend Uncertainties ZIM Integrated Shipping: I'm Not Playing The Merger Roulette ZIM Integrated GAAP EPS of -$0.71 misses by $0.33, revenue of $1.4B misses by $60M ZIM Integrated Q1 2026 Earnings Preview
French defence group Thales and Alphabet's Google Cloud have signed a deal to launch a new European cloud solution in Germany that will be operationally and legally independent from Google, the companies said on Wednesday. (Reporting by Gianluca Lo Nostro; Editing by Matt Scuffham)
French defence group Thales and Alphabet's Google Cloud have signed a deal to launch a new European cloud solution in Germany that will be operationally and legally independent from Google, the companies said on Wednesday. (Reporting by Gianluca Lo Nostro; Editing by Matt Scuffham)
JHVEPhoto Hasbro ( HAS ) reported a 12.7% year-over-year increase in revenue for its fiscal first quarter, driven by strong growth in its Wizards and Digital Gaming segment, which rose 26%, while Consumer Products remained flat and Entertainment declined 24%. Adjusted operating profit was up 29% to $287M during the quarter that ended on March 29, reflecting favorable product mix and topline streng...
JHVEPhoto Hasbro ( HAS ) reported a 12.7% year-over-year increase in revenue for its fiscal first quarter, driven by strong growth in its Wizards and Digital Gaming segment, which rose 26%, while Consumer Products remained flat and Entertainment declined 24%. Adjusted operating profit was up 29% to $287M during the quarter that ended on March 29, reflecting favorable product mix and topline strength. Adjusted EPS came in at $1.47 vs. $1.29 consensus and $1.04 a year ago. Hasbro ( HAS ) said the Wizards segment benefited from a 36% increase in MAGIC: THE GATHERING revenue, supported by new releases and continued back-catalog strength, while Monopoly Go! contributed $41M. Consumer Products performance was steady, with gains in key categories offset by tough prior-year licensing comparisons. The Entertainment segment saw lower revenue due to deal timing but improved profitability from reduced royalty expenses. On the capital allocation front, Hasbro ( HAS ) returned $106M to shareholders and allocated $96M toward debt reduction, including issuing $400M in new notes to refinance upcoming maturities and repurchase higher-cost debt. Looking ahead, Hasbro ( HAS ) continues to expect revenue to be up 3% to 5% in constant currency, an adjusted operating margin of 24% to 25%, and adjusted EBITDA of $1.40B to $1.45B (midpoint $1.425B) vs. the consensus estimate of $1.44B. "We remain focused on delivering our annual objectives by driving operating leverage, investing behind our highest-return brands, and returning cash to shareholders as we build on this solid start to the year," highlighted CFO Gina Goetter. Shares of Hasbro ( HAS ) edged 0.3% higher in premarket trading on Wednesday after gaining 3.7% on Tuesday. More on Hasbro Hasbro: Magic Is Working, But I'm Not Spellbound Hasbro: MAGIC Strength Increasingly Reflected (Downgrade) Hasbro reports mixed Q1 results; reaffirms FY26 outlook Hasbro Q1 2026 Earnings Preview Seeking Alpha’s Quant Rating on Hasbro